HeartFlow plans a $100M IPO to fund R&D and new products despite financial risks. Read about its prospects, challenges, and ...

The company reported revenue of $37.2 million in the first quarter, up 39% year over year, but said it has faced challenges ...

Heartflow is once again looking for a path to go public, with a filing for a Nasdaq IPO. | The former Fierce Medtech Fierce ...

Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S.

This summary covers significant health news including FDA advisers rejecting Otsuka's PTSD treatment, Getinge exceeding ...

Heartflow, an artificial intelligence-based medical device software developer, filed for an initial public offering in the United States on Thursday. The U.S. IPO market is witnessing a renewed vigor ...

In a bold bid to electrify Wall Street and revolutionize how heart disease is diagnosed, Heartflow, a medical technology ...

Such well-funded companies are ripe targets for IPO. Heartflow has been venture-backed since 2009, ramped up the amounts it has raised consistently – with a $100+ million round that wrapped up ...

Largest commercial insurer in the United States releases positive comprehensive coverage for AI-enabled Heartflow Plaque Analysis to support precise diagnosis and management of patientsMOUNTAIN VIEW, ...

The firm found that companies tended to IPO at an age of about 10 years and after raising roughly $200 million. ... HeartFlow has a $1.56 billion valuation, according to PitchBook.

HeartFlow recently filed a Form S-1 with the SEC to confirm its intent to complete an initial public offering (IPO) and go ...